TITLE

Estimating dose-response effects in psychological treatment trials: the role of instrumental variables

AUTHOR(S)
Maracy, Mohammad; Dunn, Graham
PUB. DATE
June 2011
SOURCE
Statistical Methods in Medical Research;Jun2011, Vol. 20 Issue 3, p191
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We present a relatively non-technical and practically orientated review of statistical methods that can be used to estimate dose—response relationships in randomised controlled psychotherapy trials in which participants fail to attend all of the planned sessions of therapy. Here we are investigating the effects on treatment outcome of the number of sessions attended when the latter is possibly subject to hidden selection effects (hidden confounding). The aim is to estimate the parameters of a structural mean model (SMM) using randomisation, and possibly randomisation by covariate interactions, as instrumental variables. We describe, compare and illustrate the equivalence of the use of a simple G-estimation algorithm and two two-stage least squares procedures that are traditionally used in economics.
ACCESSION #
60979552

 

Related Articles

  • Identification of causal effects on binary outcomes using structural mean models. Clarke, Paul S.; Windmeijer, Frank // Biostatistics;Oct2010, Vol. 11 Issue 4, p756 

    Structural mean models (SMMs) were originally formulated to estimate causal effects among those selecting treatment in randomized controlled trials affected by nonignorable noncompliance. It has already been established that SMMs can identify these causal effects in randomized placebo controlled...

  • Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers. Seitz, Lisa; Jin, Lixia; Leleti, Manmohan; Ashok, Devika; Jeffrey, Jenna; Rieger, Aimee; Tiessen, Renger G.; Arold, Gerhard; Tan, Joanne B. L.; Powers, Jay P.; Walters, Matthew J.; Karakunnel, Joyson // Investigational New Drugs;Aug2019, Vol. 37 Issue 4, p711 

    Summary: Adenosine suppresses antitumor immune responses via A2a and A2b receptors expressed on intratumoral immune cells. This effect is mediated by increased cyclic adenosine 5′-monophosphate (AMP) levels and phosphorylation of cyclic AMP response element binding protein (CREB). We...

  • VII. Discontinuity Design.  // Working Papers (FEP) -- Universidade do Porto; 

    The article discusses the discontinuity design estimator (DD) of the paper entitled "Alternative Approaches to Evaluation in Empirical Microeconomics." It states that discontinuity design estimator (DD) uses the discontinuous dependence of d on z to identify a local average treatment effect even...

  • Rifampicin Prophylaxis for Leprosy.  // Clinical Infectious Diseases;7/1/2008, Vol. 47 Issue 1, pv 

    The article presents the summary of medical study that examined the effectiveness of single dose rifampicin as a preventive therapy for leprosy. The study, which was conducted in northwestern Bangladesh, used a cluster randomization method in which a cluster is composed of contacts of single...

  • Estimating unbiased treatment effects in education using a regression discontinuity design. Smith, William C. // Practical Assessment, Research & Evaluation;Aug2014, Vol. 19 Issue 8/9, p1 

    The ability of regression discontinuity (RD) designs to provide an unbiased treatment effect while overcoming the ethical concerns plagued by Random Control Trials (RCTs) make it a valuable and useful approach in education evaluation. RD is the only explicitly recognized quasi-experimental...

  • Potential Misinterpretation of Treatment Effects Due to Use of Odds Ratios and Logistic Regression in Randomized Controlled Trials. Knol, Mirjam J.; Duijnhoven, Ruben G.; Grobbee, Diederick E.; Moons, Karel G. M.; Groenwold, Rolf H. H. // PLoS ONE;2011, Vol. 6 Issue 6, p1 

    Background: In randomized controlled trials (RCTs), the odds ratio (OR) can substantially overestimate the risk ratio (RR) if the incidence of the outcome is over 10%. This study determined the frequency of use of ORs, the frequency of overestimation of the OR as compared with its accompanying...

  • Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it? Bassler, Dirk; Montori, Victor M; Briel, Matthias; Glasziou, Paul; Walter, Stephen D; Ramsay, Tim; Guyatt, Gordon // Statistical Methods in Medical Research;Apr2013, Vol. 22 Issue 2, p159 

    We review controversies associated with randomized controlled trials (RCTs) stopped early for apparent benefit (truncated RCTs or tRCTs) and present our groups’ perspective. Long-established theory, simulations and recent empirical evidence demonstrate that tRCTs will on average...

  • Dose–response to 3 months of quercetin-containing supplements on metabolite and quercetin conjugate profile in adults. Cialdella-Kam, Lynn; Nieman, David C.; Sha, Wei; Meaney, Mary Pat; Knab, Amy M.; Shanely, R. Andrew // British Journal of Nutrition;6/14/2013, Vol. 109 Issue 11, p1923 

    Quercetin, a flavonol in fruits and vegetables, has been demonstrated to have antioxidant, anti-inflammatory and immunomodulating influences. The purpose of the present study was to determine if quercetin, vitamin C and niacin supplements (Q-500 = 500 mg/d of quercetin, 125 mg/d of vitamin C and...

  • Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Theuwissen, Elke; Cranenburg, Ellen C.; Knapen, Marjo H.; Magdeleyns, Elke J.; Teunissen, Kirsten J.; Schurgers, Leon J.; Smit, Egbert; Vermeer, Cees // British Journal of Nutrition;11/14/2012, Vol. 108 Issue 9, p1652 

    Vitamin K is required for the carboxylation of Gla-proteins in the liver (coagulation factors) and extra-hepatic tissues, such as bone (osteocalcin, OC), and arterial wall (matrix Gla-protein, MGP). Although the coagulation factors are essentially fully carboxylated under normal conditions,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics